Literature DB >> 26241531

Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features.

M Ciresa1, A M De Gaetano, M Pompili, A Saviano, A Infante, M Montagna, A Guerra, M Giuga, M Vellone, F Ardito, A De Rose, F Giuliante, F M Vecchio, A Gasbarrini, L Bonomo.   

Abstract

OBJECTIVE: Incidence of intrahepatic mass-forming cholangiocarcinoma (IMCC) is increasing worldwide, especially in patients with chronic liver disease. The small and the histologically well-differentiated IMCCs in chronic liver disease could be arterially hypervascular lesions with/without washout on computed tomography (CT) and magnetic resonance imaging (MRI), mimicking typical hepatocellular carcinoma (HCC). The aim of this work is to evaluate contrast enhancement (CE) patterns of IMCCs at quadri-phasic multidetector CT (4-MDCT) and MRI, using imaging-clinicopathologic correlation. PATIENTS AND METHODS: The 4-MDCT and MR images of 56 histologically confirmed IMCCs were retrospectively evaluated for tumor morphology and enhancement features. Enhancement pattern was defined according to the behavior of the nodule in arterial (AP), portal venous (PVP) and equilibrium phases (EP), and dynamic pattern was described according to enhancement progression throughout the different phases. Arterial and dynamic enhancement patterns were correlated with chronic liver disease, tumor size and histological differentiation.
RESULTS: Most of the nodules were peripherally hyperenhancing (50%) on AP, and partially hyperenhancing on PVP (67.9%) and EP (80.3%). Forty-six (82.1%) IMCCs showed progressive CE, 7 (12.5%) stable CE and 3 (5.4%) wash-out. In normal liver there were 34 nodules with progressive and 3 with stable CE, whereas in chronic liver disease there were 12 IMCCs with progressive, 4 with stable and 3 with washout pattern (p = 0.01); IMCCs with progressive CE were more differentiated than IMCCs with stable CE and wash-out (p = 0.02).
CONCLUSIONS: The most prevalent enhancement pattern of IMCCs was arterial rim enhancement followed by progressive and concentric filling. The stable and the washout patterns were more frequent in poorly differentiated IMCCs. Contrast washout was observed only in IMCCs emerging in chronic liver disease with a risk of misdiagnosis with HCC.

Entities:  

Mesh:

Year:  2015        PMID: 26241531

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  14 in total

1.  Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.

Authors:  Ting Ni; Xiao-Sha Shang; Wen-Tao Wang; Xin-Xing Hu; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  Br J Radiol       Date:  2018-06-05       Impact factor: 3.039

Review 2.  Surgical options for intrahepatic cholangiocarcinoma.

Authors:  Kui Wang; Han Zhang; Yong Xia; Jian Liu; Feng Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

3.  Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features.

Authors:  Yong Zhu; Jun Chen; Weiwei Kong; Liang Mao; Wentao Kong; Qun Zhou; Zhengyang Zhou; Bin Zhu; Zhongqiu Wang; Jian He; Yudong Qiu
Journal:  Eur Radiol       Date:  2017-07-27       Impact factor: 5.315

4.  Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018.

Authors:  Xianlun Zou; Yan Luo; John N Morelli; Xuemei Hu; Yaqi Shen; Daoyu Hu
Journal:  Abdom Radiol (NY)       Date:  2021-03-03

5.  Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC).

Authors:  Kai-Pu Jin; Rou-Fan Sheng; Chun Yang; Meng-Su Zeng
Journal:  Abdom Radiol (NY)       Date:  2021-11-25

6.  A rare case of intrahepatic cholangiocarcinoma with tumor thrombus in the bile duct.

Authors:  Atsushi Nanashima; Kunihiko Tominaga; Akihiro Yonei; Ryo Sekiya; Syoutaro Oshikawa; Yuichiro Sato; Norio Wake; Jun Akiba
Journal:  Clin J Gastroenterol       Date:  2020-10-30

7.  Predicting peritumoral Glisson's sheath invasion of intrahepatic cholangiocarcinoma with preoperative CT imaging.

Authors:  Yingfan Mao; Yong Zhu; Yudong Qiu; Weiwei Kong; Liang Mao; Qun Zhou; Jun Chen; Jian He
Journal:  Quant Imaging Med Surg       Date:  2019-02

8.  Contrast-enhanced multiple-phase imaging features of intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma with cirrhosis: A comparative study.

Authors:  Ying Chen; Yao Pan; Ke-Ren Shen; Xiu-Liang Zhu; Chen-Ying Lu; Qing-Hai Li; Shu-Gao Han; Yan-Biao Fu; Xiu-Fang Xu; Ri-Sheng Yu
Journal:  Oncol Lett       Date:  2017-07-24       Impact factor: 2.967

9.  Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis.

Authors:  Zhenjie Li; Lisha Mou; Haibin Gao; Yi Zeng; Xueyi Tang; Xuesong Deng; Zuhui Pu; Yong Ni; Yongqiang Zhan
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 10.  Role of liver biopsy in hepatocellular carcinoma.

Authors:  Luca Di Tommaso; Marco Spadaccini; Matteo Donadon; Nicola Personeni; Abubaker Elamin; Alessio Aghemo; Ana Lleo
Journal:  World J Gastroenterol       Date:  2019-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.